Advice for community physicians treating HER2+ breast cancer.
Matthew Fowler, Associate Editor
Advertisement
Articles by Matthew Fowler, Associate Editor
Dr. Virginia Kaklamani discusses the role of maintenance therapies for HER2+ breast cancer.
Virginia Kaklamani, MD, DSc, provides an overview of the goals of care for HER2+ breast cancer.
A review of the currently available frontline treatment options for HER2+ breast cancer.
Virginia Kaklamani, MD, DSc, provides an overview of the goals of care for HER2+ breast cancer.
Advertisement
Latest Updated Articles
HER2+ Breast Cancer and the Role of Maintenance TherapiesPublished: February 8th 2022 | Updated:
- Goals of Care for HER2+ Breast Cancer
Published: February 1st 2022 | Updated:
- Clinical Trial Data in HER2+ Breast Cancer
Published: February 8th 2022 | Updated:
- HER2+ Breast Cancer: Frontline Treatment Options
Published: February 1st 2022 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
AI-Powered Scout Platform Could Enhance Oncology Decision-Making With Data- and Expert-Driven Insights
2
Molecular Insights Into Cancer Cachexia: An Evolution in Identifying the Syndrome
3
FDA Grants Interchangeability Designation to 2 Denosumab Biosimilars
4
Sac-TMT Combo Produces Encouraging Activity in Pretreated Metastatic CRPC
5
